Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
about
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurityOcular medicines in children: the regulatory situation related to clinical researchDelayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity.Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report.Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.[Pharmacological treatment for retinopathy of prematurity].Anti-VEGF Agents for Ocular Angiogenesis and Vascular PermeabilityIntravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.Intravitreal Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Several Years On.Intravitreal injection of bevacizumab for retinopathy of prematurity.Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up.Endothelial nicotinic acetylcholine receptors and angiogenesis.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurityCurrent and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.Effects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case series.Effect of intravitreal bevacizumab (avastin) on the growing rabbit eye.Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?Systemic effects after intravitreal injection of bevacizumab in new born rabbit eyes.Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity.
P2860
Q24609568-621D40FF-DC76-4073-92A3-C27BE17F823BQ27027227-CE0FDA6F-4E65-4C8D-865B-1D377951B6E7Q31065277-F5A0013D-B26A-4542-A5E5-D05BE6645E8DQ33745089-C78EABDF-C407-4376-857F-E4CAF3636468Q33873875-D7EEA8C8-C571-4417-8D69-F8CA62471C6BQ33997311-F16350CC-F982-469E-83AD-B17125C059DFQ34088274-38D1EAF6-8504-49C1-8287-3587A32F0B3BQ34234070-C92ADA25-2E0D-4C8F-9244-14D645A0399AQ34339456-59078566-D82F-4234-8B38-1BD9A1FE0CBFQ34355895-4D122316-6C47-42D6-B682-8484592E64B5Q35002314-08962711-C5F0-409C-B978-550DC5F21C70Q35102460-74C806CF-3019-4B74-A12A-22C293F0488CQ35610708-76C1B8CF-0D78-4146-9514-225B4999C178Q35665701-444985CD-15BB-4850-BECE-2AD985725A14Q36686806-3DA185B6-DDA4-43B4-9F00-523A3BC9F0CCQ37397988-136AA5BB-9BB0-4D80-902A-F01D1B147E45Q37627442-90DA03F5-6D86-4BFF-B12C-5CD6186F643BQ37658654-092D2718-4997-4AFB-98D6-18E07005F76AQ38192060-BB42409C-6DB9-460C-AFAC-47AD1A1A3604Q42653010-810107F1-766E-4BD4-95EB-FFD6CB6E78FAQ43245686-A568E681-B0F8-4691-B700-7E61D867886FQ45974194-57457E36-4CD2-42ED-B5E3-C86F93AD509AQ48018646-A82737E1-0974-4682-B3B3-7A2F781053CFQ55461780-38EB00EB-F6F8-4A59-B4C9-FA5A2079C3F2
P2860
Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@ast
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@en
Off-label use of intravitreal bevacizumab
@nl
type
label
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@ast
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@en
Off-label use of intravitreal bevacizumab
@nl
prefLabel
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@ast
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@en
Off-label use of intravitreal bevacizumab
@nl
P2093
P1433
P1476
Off-label use of intravitreal ...... ld retinopathy of prematurity.
@en
P2093
Carmen A Puliafito
Ditte Hess
Geeta A Lalwani
Maria Buch
Rose A Johnson
Scott Cardone
Timothy G Murray
P356
10.1097/IAE.0B013E3181644AD2
P433
P577
2008-03-01T00:00:00Z